Detection of AGEs as markers for carbohydrate metabolism and protein denaturation

Journal of Clinical Biochemistry and Nutrition

Volumn 55, Issue 1, 2014, Pages 1-6

  Nagai, Ryoji ^a   Shirakawa, Jun Ichi ^a   Fujiwara, Yukio ^b   Ohno, Rei Ichi ^a   Moroishi, Narumi ^a   Sakata, Noriyuki ^c   Nagai, Mime ^a  

^a TOKAI UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c FUKUOKA UNIVERSITY   (Japan)

Author keywords

AGEs; Aging; Diabetic complications; Glycation; Post translational modification

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CARBOHYDRATE; GLUCOSE; PLASMINOGEN ACTIVATOR; PROTEIN; SCAVENGER RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

CARBOHYDRATE METABOLISM; CITRIC ACID CYCLE; CONJUGATION; CROSS LINKING; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE BLOOD LEVEL; GLYCATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNE RESPONSE; IMMUNOCHEMISTRY; INSULIN RESISTANCE; LIFESTYLE; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR WEIGHT; NONHUMAN; OBESITY; OXIDATIVE STRESS; PHYSICAL CHEMISTRY; PROTEIN DENATURATION; PROTEIN MODIFICATION; PROTEIN PROCESSING; REVIEW; TANDEM MASS SPECTROMETRY;

EID: 84904615335     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.13-112     Document Type: Review

References (29)

1. Monnier VM, Kohn RR, Cerami A. Accelerated age-related browning of human collagen in diabetes mellitus. Proc Natl Acad Sci USA 1984; 81: 583-587. (Pubitemid 14186609)
2. Nakayama H, Taneda S, Mitsuhashi T, et al. Characterization of antibodies to advanced glycosylation end products on protein. J Immunol Methods 1991; 140: 119-125.
3. Horiuchi S, Araki N, Morino Y. Immunochemical approach to characterize advanced glycation end products of the Maillard reaction. Evidence for the presence of a common structure. J Biol Chem 1991; 266: 7329-7332.
4. Koito W, Araki T, Horiuchi S, Nagai R. Conventional antibody against Nepsilon-(carboxymethyl)lysine (CML) shows cross-reaction to Nepsilon- (carboxyethyl)lysine (CEL): immunochemical quantification of CML with a specific antibody. J Biochem 2004; 136: 831-837. (Pubitemid 40364174)
5. ε-(carboxymethyl)lysine formation from Amadori product. Biochem Biophys Res Commun 1997; 234: 167-172.
6. ε-(carboxymethyl)lysine by the cleavage of Amadori product and generation of glucosone and glyoxal from glucose: novel pathways for protein modification by peroxynitrite. Diabetes 2002; 51: 2833-2839.
7. ε-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. Biochem J 1997; 324: 565-570.
8. Mera K, Nagai M, Brock JW, et al. Glutaraldehyde is an effective cross-linker for production of antibodies against advanced glycation end-products. J Immunol Methods 2008; 334: 82-90.
9. Nagai R, Hayashi CM, Xia L, Takeya M, Horiuchi S. Identification in human atherosclerotic lesions of GA-pyridine, a novel structure derived from glycolaldehyde-modified proteins. J Biol Chem 2002; 277: 48905-48912. (Pubitemid 35470860)
10. Sanaka T, Funaki T, Tanaka T, et al. Plasma pentosidine levels measured by a newly developed method using ELISA in patients with chronic renal failure. Nephron 2002; 91: 64-73. (Pubitemid 34522834)
11. Nakano M, Kubota M, Owada S, Nagai R. The pentosidine concentration in human blood specimens is affected by heating. Amino Acids 2013; 44: 1451-1456.
12. ε-(carboxymethyl)lysine by short-term heating: possible detection of artifacts by immunohistochemistry. Lab Invest 2002; 82: 795-808.
13. Thornalley PJ, Langborg A, Minhas HS. Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem J 1999; 344: 109-116.
14. McLellan AC, Thornalley PJ, Benn J, Sonksen PH. Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications. Clin Sci (Lond) 1994; 87: 21-29. (Pubitemid 24220267)
15. Makino H, Shikata K, Hironaka K, et al. Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy. Kidney Int 1995; 48: 517-526.
16. Murata T, Nagai R, Ishibashi T, Inomuta H, Ikeda K, Horiuchi S. The relationship between accumulation of advanced glycation end products and expression of vascular endothelial growth factor in human diabetic retinas. Diabetologia 1997; 40: 764-769. (Pubitemid 27306953)
17. Brownlee M, Vlassara H, Kooney A, Ulrich P, Cerami A. Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 1986; 232: 1629-1632. (Pubitemid 16095602)
18. Babaei-Jadidi R, Karachalias N, Ahmed N, Battah S, Thornalley PJ. Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine. Diabetes 2003; 52: 2110-2120. (Pubitemid 36919806)
19. Hammes HP, Du X, Edelstein D, et al. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat Med 2003; 9: 294-299. (Pubitemid 36362784)
20. Degenhardt TP, Alderson NL, Arrington DD, et al. Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat. Kidney Int 2002; 61: 939-950. (Pubitemid 34175462)
21. Stitt A, Gardiner TA, Alderson NL, et al. The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. Diabetes 2002; 51: 2826-2832. (Pubitemid 34970937)
22. Motomura K, Fujiwara Y, Kiyota N, et al. Astragalosides isolated from the root of astragalus radix inhibit the formation of advanced glycation end products. J Agric Food Chem 2009; 57: 7666-7672.
23. ε-(carboxymethyl) lysine of the Maillard reaction. Free Radic Biol Med 2011; 50: 883-891.
24. Nagai R, Brock JW, Blatnik M, et al. Succination of protein thiols during adipocyte maturation: a biomarker of mitochondrial stress. J Biol Chem 2007; 282: 34219-34228. (Pubitemid 350159439)
25. Frizzell N, Rajesh M, Jepson MJ, et al. Succination of thiol groups in adipose tissue proteins in diabetes: succination inhibits polymerization and secretion of adiponectin. J Biol Chem 2009; 284: 25772-25781.
26. Alderson NL, Wang Y, Blatnik M, et al. S-(2-Succinyl)cysteine: a novel chemical modification of tissue proteins by a Krebs cycle intermediate. Arch Biochem Biophys. 2006; 450: 1-8. (Pubitemid 43782733)
27. Higashi T, Sano H, Saishoji T, et al. The receptor for advanced glycation end products mediates the chemotaxis of rabbit smooth muscle cells. Diabetes 1997; 46: 463-472. (Pubitemid 27090277)
28. Nagai R, Mera K, Nakajou K, et al. The ligand activity of AGE-proteins to scavenger receptors is dependent on their rate of modification by AGEs. Biochim Biophys Acta 2007; 1772: 1192-1198.
29. Thornalley PJ, Argirova M, Ahmed N, Mann VM, Argirov O, Dawnay A. Mass spectrometric monitoring of albumin in uremia. Kidney Int 2000; 58: 2228-2234.